Related Experiment Videos

[Ginsenoside Rg3 induces apoptosis of human lung squamous cell carcinoma SK-MES-1 cell line]

Xin Wang1, Yu-ling Zheng, Ke Li

  • 1Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. wxgoal@163.com

Abstract

Insights

Ginsenoside Rg3 promotes apoptosis in lung cancer cells by reducing survivin expression. This natural compound offers a potential therapeutic strategy for lung squamous cell carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Lung squamous cell carcinoma (LSCC) is a major subtype of non-small cell lung cancer.
  • Survivin is an anti-apoptotic protein often overexpressed in cancers, including LSCC.
  • Ginsenoside Rg3 is a natural compound derived from ginseng with potential anti-cancer properties.

Purpose of the Study:

  • To evaluate the impact of ginsenoside Rg3 on apoptosis in the human LSCC cell line SK-MES-1.
  • To investigate the effect of ginsenoside Rg3 on survivin protein and mRNA expression in SK-MES-1 cells.

Main Methods:

  • SK-MES-1 cells were treated with ginsenoside Rg3, with blank and arsenic trioxide controls.
  • Apoptotic rates were quantified using flow cytometry.
  • Survivin protein and mRNA levels were assessed via immunocytochemistry and RT-PCR, respectively.

Main Results:

  • Ginsenoside Rg3 treatment dose-dependently increased the apoptotic rate of SK-MES-1 cells after 48 hours.
  • Significant downregulation of both survivin protein and mRNA was observed in ginsenoside Rg3-treated cells compared to controls (P<0.05).

Conclusions:

  • Ginsenoside Rg3 effectively induces apoptosis in human lung squamous cell carcinoma SK-MES-1 cells.
  • The mechanism underlying ginsenoside Rg3-induced apoptosis may involve the inhibition of survivin expression.

Related Concept Videos